Lifeway Foods, Inc.
Lifeway Foods, Inc. (LWAY) Financial Performance & Income Statement Overview
Analyze Lifeway Foods, Inc. (LWAY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Lifeway Foods, Inc. (LWAY) Income Statement & Financial Overview
View the income breakdown for Lifeway Foods, Inc. LWAY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $46.09M | $46.93M | $46.09M | $49.16M |
| Cost of Revenue | $35.06M | $35.04M | $34.23M | $36.02M |
| Gross Profit | $11.04M | $11.90M | $11.87M | $13.14M |
| Gross Profit Ratio | $0.24 | $0.25 | $0.26 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.33M | $11.05M | $7.54M | $7.75M |
| Operating Expenses | $9.46M | $11.18M | $7.68M | $7.75M |
| Total Costs & Expenses | $44.52M | $46.22M | $41.91M | $43.77M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$14000.00 | $3000.00 | $4000.00 | $47000.00 |
| Depreciation & Amortization | $0.00 | $899000.00 | $855000.00 | $836000.00 |
| EBITDA | $1.57M | $1.68M | $5.18M | $6.24M |
| EBITDA Ratio | $0.03 | $0.04 | $0.11 | $0.13 |
| Operating Income | $1.57M | $713000.00 | $4.19M | $5.39M |
| Operating Income Ratio | $0.03 | $0.02 | $0.09 | $0.11 |
| Other Income/Expenses (Net) | $3.39M | $63000.00 | $137000.00 | -$27000.00 |
| Income Before Tax | $4.97M | $776000.00 | $4.33M | $5.36M |
| Income Before Tax Ratio | $0.11 | $0.02 | $0.09 | $0.11 |
| Income Tax Expense | $1.43M | $936000.00 | $1.35M | $1.58M |
| Net Income | $3.54M | -$160000.00 | $2.98M | $3.78M |
| Net Income Ratio | $0.08 | -$0.003 | $0.06 | $0.08 |
| EPS | $0.00 | -$0.01 | $0.20 | $0.26 |
| Diluted EPS | $0.00 | -$0.01 | $0.19 | $0.25 |
| Weighted Avg Shares Outstanding | $0.00 | $14.77M | $14.80M | $14.73M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $14.86M | $15.27M | $15.20M |
Over the past four quarters, Lifeway Foods, Inc. demonstrated steady revenue growth, increasing from $49.16M in Q2 2024 to $46.09M in Q1 2025. Operating income reached $1.57M in Q1 2025, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.57M, reflecting operational efficiency. Net income rose to $3.54M, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan